The Extrapulmonary Origin of Fibroblasts: Stem/Progenitor Cells and Beyond, Proceedings of the American Thoracic Society, vol.3, issue.4, pp.373-376, 2006. ,
DOI : 10.1513/pats.200512-133TK
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.7, pp.588-594, 2009. ,
DOI : 10.1164/rccm.200810-1534OC
Bone marrow???derived progenitor cells in pulmonary fibrosis, Journal of Clinical Investigation, vol.113, issue.2, pp.243-252, 2004. ,
DOI : 10.1172/JCI200418847
Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair, Mol Med, vol.1, pp.71-81, 1994. ,
Fibrocytes: a unique cell population implicated in wound healing, Cellular and Molecular Life Sciences (CMLS), vol.60, issue.7, pp.1342-1350, 2003. ,
DOI : 10.1007/s00018-003-2328-0
The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy, Current Stem Cell Research & Therapy, vol.4, issue.4, pp.266-80, 2009. ,
DOI : 10.2174/157488809789649232
CCR2-Mediated Recruitment of Fibrocytes to the Alveolar Space after Fibrotic Injury, The American Journal of Pathology, vol.166, issue.3, pp.675-684, 2005. ,
DOI : 10.1016/S0002-9440(10)62289-4
Reduction of Bleomycin-Induced Pulmonary Fibrosis by Serum Amyloid P, The Journal of Immunology, vol.179, issue.6, pp.4035-4044, 2007. ,
DOI : 10.4049/jimmunol.179.6.4035
Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide, Fibrogenesis & Tissue Repair, vol.4, issue.1, p.15, 2011. ,
DOI : 10.1002/art.1780230510
Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury*, Critical Care Medicine, vol.40, issue.1, pp.21-29, 2012. ,
DOI : 10.1097/CCM.0b013e31822d718b
Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury, AJP: Lung Cellular and Molecular Physiology, vol.294, issue.2, pp.334-343, 2008. ,
DOI : 10.1152/ajplung.00096.2007
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.6, pp.788-824, 2011. ,
DOI : 10.1164/rccm.2009-040GL
Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring., American Journal of Roentgenology, vol.169, issue.4, pp.977-983, 1997. ,
DOI : 10.2214/ajr.169.4.9308447
Acute Exacerbations of Idiopathic Pulmonary Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.7, pp.636-643, 2007. ,
DOI : 10.1164/rccm.200703-463PP
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.4, pp.431-440, 2011. ,
DOI : 10.1164/rccm.201006-0894CI
Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance, European Respiratory Journal, vol.35, issue.6, pp.1312-1321, 2010. ,
DOI : 10.1183/09031936.00074709
Fibrocytes: emerging effector cells in chronic inflammation, Nature Reviews Immunology, vol.23, issue.6, pp.427-435, 2011. ,
DOI : 10.1038/nri2990
Correlation between circulating fibrocytes, and activity and progression of interstitial lung diseases, Respirology, vol.164, issue.4, pp.693-701, 2012. ,
DOI : 10.1111/j.1440-1843.2012.02167.x
Role of semaphorin 7a signaling in transforming growth factor ?1-induced lung fibrosis and scleroderma-related interstitial lung disease, Arthritis & Rheumatism, vol.106, issue.8, pp.2484-2494, 2011. ,
DOI : 10.1002/art.30386
Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis, The International Journal of Biochemistry & Cell Biology, vol.40, issue.10, pp.2129-2140, 2008. ,
DOI : 10.1016/j.biocel.2008.02.012
The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy, Current Stem Cell Research & Therapy, vol.4, issue.4, pp.266-280, 2009. ,
DOI : 10.2174/157488809789649232
Fibrocytes in chronic lung disease ? Facts and controversies, Pulmonary Pharmacology & Therapeutics, vol.25, issue.4, pp.263-267, 2012. ,
DOI : 10.1016/j.pupt.2011.09.002
Dendritic Cells Accumulate in Human Fibrotic Interstitial Lung Disease, American Journal of Respiratory and Critical Care Medicine, vol.176, issue.10, pp.1007-1014, 2007. ,
DOI : 10.1164/rccm.200609-1347OC
Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts, Molecular and Cellular Biochemistry, vol.15, issue.1, pp.11-21, 2010. ,
DOI : 10.1007/s11010-010-0524-4
Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4, Journal of Biological Chemistry, vol.277, issue.18, pp.15677-15689, 2002. ,
DOI : 10.1074/jbc.M111388200
URL : https://hal.archives-ouvertes.fr/pasteur-00166872
Elastase Release by Transmigrating Neutrophils Deactivates Endothelial-bound SDF-1?? and Attenuates Subsequent T Lymphocyte Transendothelial Migration, The Journal of Experimental Medicine, vol.63, issue.6, pp.713-724, 2004. ,
DOI : 10.1172/JCI200315994
URL : https://hal.archives-ouvertes.fr/pasteur-00166857
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts, Journal of Clinical Investigation, vol.117, issue.4, pp.989-996, 2007. ,
DOI : 10.1172/JCI29713
Morphological and Biochemical Properties of Alveolar Fibroblasts in Interstitial Lung Diseases, Lung, vol.179, issue.2, pp.105-117, 2001. ,
DOI : 10.1007/s004080000051